Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies

被引：29
|
作者：
Sorrentino, Claudia [1 ]
Cuneo, Antonio [1 ,2 ]
Roti, Giovanni [1 ]
机构：
[1] Univ Parma, Dept Med & Surg, I-43126 Parma, Italy
[2] Univ Ferrara, Dept Med Sci, I-44121 Ferrara, Italy
来源：
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | 2019年 / 11卷
关键词：
NOTCH1; Targeted therapy; T-cell acute lymphoblastic leukemia; Chronic lymphocytic leukemia; Mantle cell lymphoma; PROTEASOME INHIBITOR BORTEZOMIB; GAMMA-SECRETASE INHIBITORS; MANTLE-CELL LYMPHOMA; ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL; B-CLL; ACTIVATING MUTATIONS; MONOCLONAL-ANTIBODY; TUMOR-GROWTH; APOPTOSIS;
D O I：
10.4084/MJHID.2019.037
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The Notch pathway plays a key role in several processes, including stem-cell self-renewal, proliferation, and cell differentiation. Several studies identified recurrent mutations in hematological malignancies making Notch one of the most desirable targets in leukemia and lymphoma. The Notch signaling mediates resistance to therapy and controls cancer stem cells supporting the development of on-target therapeutic strategies to improve patients' outcome. In this brief review, we outline the therapeutic potential of targeting Notch pathway in T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and mantle cell lymphoma.
引用
收藏
页数：13
相关论文
共 50 条
  • [1] Notch signaling: its roles and therapeutic potential in hematological malignancies
    Gu, Yisu
    Masiero, Massimo
    Banham, Alison H.
    ONCOTARGET, 2016, 7 (20) : 29804 - 29823
  • [2] Targeting Notch as a Therapeutic Approach for Human Malignancies
    Platonova, Natalia
    Lesma, Elena
    Basile, Andrea
    Bignotto, Monica
    Garavelli, Silvia
    Palano, Maria Teresa
    Moschini, Adriana
    Neri, Antonino
    Colombo, Michela
    Chiaramonte, Raffaella
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (01) : 108 - 134
  • [3] Editorial: The notch signaling pathway in lymphoid malignancies
    Fais, Franco
    Efremov, Dimitar G.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [4] Therapeutic Neovascularization Targeting Notch Signaling
    Tateno, Kaoru
    Minamino, Tohru
    Yoshida, Yohko
    Moriya, Junji
    Okada, Sho
    Shimizu, Ippei
    Yokoyama, Masataka
    Ito, Takashi
    Nojima, Aika
    Komuro, Issei
    Kobayashi, Yoshio
    CIRCULATION, 2011, 124 (21)
  • [5] Therapeutic targeting of Notch signaling in cancer
    Brahmi, Mehdi
    Bally, Olivia
    Eberst, Lauriane
    Cassier, Philippe
    BULLETIN DU CANCER, 2017, 104 (10) : 883 - 891
  • [6] The Notch signaling pathway in hematopoiesis and hematologic malignancies
    Schwanbeck, Ralf
    Just, Ursula
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (12): : 1735 - U21
  • [7] Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies
    Markouli, Mariam
    Strepkos, Dimitrios
    Piperi, Christina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [8] Targeting the canonical Wnt/-catenin pathway in hematological malignancies
    Ashihara, Eishi
    Takada, Tetsuya
    Maekawa, Taira
    CANCER SCIENCE, 2015, 106 (06) : 665 - 671
  • [9] Notch Signaling: A Potential Therapeutic Target for Hematologic Malignancies
    Gao, Lingbao
    Yuan, Keyu
    Ding, Wei
    Lin, Mei
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2016, 26 (03): : 239 - 246
  • [10] Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme
    Gersey, Zachary
    Osiason, Adam D.
    Bloom, Laura
    Shah, Sumedh
    Thompson, John W.
    Bregy, Amade
    Agarwal, Nitin
    Komotar, Ricardo J.
    WORLD NEUROSURGERY, 2019, 131 : 252 - +
12345